KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$262000.0.

  • Vir Biotechnology's Gains from Investment Securities rose 7681.42% to -$262000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 5892.69%. This contributed to the annual value of $5.5 million for FY2024, which is 7474.42% down from last year.
  • Latest data reveals that Vir Biotechnology reported Gains from Investment Securities of -$262000.0 as of Q3 2025, which was up 7681.42% from $14.0 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Gains from Investment Securities ranged from a high of $95.0 million in Q1 2022 and a low of -$372.0 million during Q4 2022
  • Over the past 5 years, Vir Biotechnology's median Gains from Investment Securities value was $1.2 million (recorded in 2024), while the average stood at -$18.7 million.
  • Per our database at Business Quant, Vir Biotechnology's Gains from Investment Securities plummeted by 183588.9% in 2021 and then soared by 15318870.97% in 2022.
  • Vir Biotechnology's Gains from Investment Securities (Quarter) stood at $26.0 million in 2021, then crashed by 1529.69% to -$372.0 million in 2022, then surged by 100.27% to $993000.0 in 2023, then grew by 18.03% to $1.2 million in 2024, then plummeted by 122.35% to -$262000.0 in 2025.
  • Its last three reported values are -$262000.0 in Q3 2025, $14.0 million for Q2 2025, and -$6.4 million during Q1 2025.